The Serine Protease Nature of the C3 and C5 Convertases of the Classical and Alternative Complement Pathways
- 1 September 1976
- journal article
- research article
- Published by Wiley in Scandinavian Journal of Immunology
- Vol. 5 (9), 1049-1055
- https://doi.org/10.1111/j.1365-3083.1976.tb03056.x
Abstract
Activated Factor B, incorporated into the cobra venom factor(CVF)-dependent C3[the 3rd complement component]/C5 convertase, was inactivated by diisopropylfluorophosphate (DFP). Inactivation was time- and dose-dependent and was enhanced by the presence of substrate. Treatment of the zymogen of Factor B with DFP effected significant inactivation. Incorporation of [3H]diisopropylphosphate into the zymogen and into the activated form of Factor B was demonstrated after [3H]DFP treatment and subsequent electrophoresis of the proteins on polyacrylamide gels containing sodium dodecyl sulfate. Inactivation of activated C2 incorporated into the classical C5 convertase was observed on DFP treatment of the enzyme. DFP also reduced the activity of the C2 zymogen. The description of their serine proteinase nature further emphasizes the close structural and functional relationship of C2 and Factor B.This publication has 32 references indexed in Scilit:
- Cobra Venom Factor: Evidence for Its Being Altered Cobra C3 (the Third Component of Complement)Science, 1976
- Enzymic activity of the second component of complementBiochemistry, 1975
- ComplementAnnual Review of Biochemistry, 1975
- EVIDENCE FOR LINKAGE BETWEEN HL-A HISTOCOMPATIBILITY GENES AND THOSE INVOLVED IN THE SYNTHESIS OF THE SECOND COMPONENT OF COMPLEMENTThe Journal of Experimental Medicine, 1974
- PROPERDIN FACTOR DThe Journal of Experimental Medicine, 1974
- The activation of Cls with purified ClrImmunochemistry, 1974
- Fragment of the third component of human complement with anaphylatoxin activityBiochemistry, 1971
- The second component of human complement (C2): Quantitative molecular analysis of its reactions in immune hemolysisImmunochemistry, 1970
- THE SECOND COMPONENT OF HUMAN COMPLEMENT: ITS ISOLATION, FRAGMENTATION BY C'1 ESTERASE, AND INCORPORATION INTO C'3 CONVERTASEThe Journal of Experimental Medicine, 1968
- ISOLATION OF ß1F-GLOBULIN FROM HUMAN SERUM AND ITS CHARACTERIZATION AS THE FIFTH COMPONENT OF COMPLEMENTThe Journal of Experimental Medicine, 1965